Trial Profile
Efficacy of Lenalidomide in patients with relapsed primary central nervous system lymphoma (PCNSL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 05 Aug 2015 New trial record